Medicine
Izervay 7 mg/0.35 mL injection
Izervay 7 mg/0.35 mL injection is a prescription medicine containing Avacincaptad pegol for intravitreal use, marketed by Astellas Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store IZERVAY in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not…
Key facts
- Active ingredient (INN)
- Avacincaptad pegol
- Brand
- Izervay
- Strength
- 7 mg/0.35 mL
- Dosage form
- Injection
- Route
- Intravitreal
- Packs
- 1 vial of 0.35 mL
- Marketing authorisation holder
- Astellas Pharma
- Manufacturer
- Astellas Pharma
- Origin register
- US FDA, United States
- Storage
- Store IZERVAY in the refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze. Prior to use, the unopened glass vial of IZERVAY may be kept at room temperature, 20°C to 25°C (68°F to 77°F), for up to 24 hours. Do not shake. Keep the vial in the original carton to protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01XA32 Avacincaptad pegol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 August 2023
- Identifiers
- RxCUI 2645112, 2645118DailyMed set ID 1642fe6a-dc26-4d20-ae6e-654af744e3bdNDC 82829-002Application NDA217225
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / .35 mL in 1 vial, single-dose | 82829-002-01 | Astellas Pharma | 19 August 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Avacincaptad pegol is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). It is available as injection for intravitreal use. MedsAcross supplies Avacincaptad pegol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Avacincaptad pegolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- IZERVAY prescribing information (Astellas Pharma) · U.S. National Library of Medicine, DailyMed
Need Izervay 7 mg/0.35 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.